Novo Nordisk, United Laboratories Say New Obesity Drug Helps Patients Lose Weight in Trial
WSJ·2026-02-24 09:11

Group 1 - The core point of the article is that Novo Nordisk's experimental obesity drug, developed in collaboration with China's United Laboratories International Holdings, has shown effectiveness in aiding weight loss during a midstage clinical trial conducted in China [1]

Novo Nordisk, United Laboratories Say New Obesity Drug Helps Patients Lose Weight in Trial - Reportify